Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pump and dump and pump and dump and pump and dump
Lol nice price action here...
Pennies getting a major pump this time of year, I’ve been holding for a long time, seems like myself and very few other genuinely know what this company is up to. Everyone can pull data out of the ether of google but repeated attempts to contact the company getting the CEOS son on a couple of occasions with absolutely zero interest in reconnecting gave me the story. I’ll play the suckers that HODL this thing. I bought majority back at .0002 so keep up the good work I’m riding free shares.
I’m surprised I got a mill filled at 2s today
Guess who’s back? Sprint is back! Back with a boat load of shares, let’s go babyyyyyyyy!
I’ll buy 1s
Sounds like someone’s in the hole, cool you’re not hiding but this is at its core another penny popper. Fundamentals and catalysts are all that move these things, not boards or investors, I’d give management a call, when I invest in these kinds of companies I hound the CO for updates. Light them up.
Until genuine “news” the bid will get pumped and smart money will dump on it
Never healthy when one guy is pumping solo
5s again lmao. Flippers dream stock. Reload gents they’ll keep pumping this.
Someone want to update me on fundamental changes with this CO? I’ll keep flipping shares until something solid comes over the wire. Thanks for the 100% today;)
5s can be taken out easy, real resistance isn’t until .0008 / .001 / .0013
What’s the deal with TCA litigation? Crescent deal. Company looks deceased.
Last PR was dodgy, current CEO seems to be backing away from the CO. Not sure the implications of that move or what the writing on the wall is. I’m averaged lower with 10% of previous holdings. If things change that number will change with it
This was the connection I was trying to figure out, I’d question the company over this, they refused my questions when I pressed. But we need some more meat to this before coming to any conclusions. I’ll lend a hand over the coming weeks to add to this.
This will move to prior highs, so long as volume remains consistently high this stock will test resistance. News or not seems likely we leave trips soon.
Unless we break 50ml daily average 13 won’t move this
I can’t believe I missed that on the long term chart lmao, recent highs were .0008 and I sold when we ran above 5/7s... man sometimes it helps to take a look back in time.
Highly doubt it
Since when was a merger on the table here? Hulogix was the only merger that has any legs. Give me an update so I can get out sure. But substance is lacking. I hope for the best...:)
I’ve reduced my exposure 90% this week, it’s always telling when you call management. I’ve not once had a clear response from anyone. David is unbothered and I’ve lost patience, I’ll take a 3x trade and move on. Good luck gents, I’ll be around but will no longer humor this company. Hopefully that 10% yields something.
Under claims.
“What is claimed is:
1. A method of producing a biomolecule in a bioreactor under simulated microgravity culture conditions comprising the steps of: selecting mammalian cells for cell culture wherein said cells are capable of producing at least one functional biomolecule selected from the group consisting of functional proteins, non-peptide hormones, vitamins and mixtures thereof; isolating the selected mammalian cells for introduction into the cell culture; placing the mammalian cells into a rotating wall vessel containing a culture media and a culture matrix; producing three dimensional cell aggregates under simulated micro gravity culture conditions; and separating at least one functional biomolecule expressed by the cell culture.”
This is what I mentioned in a previous post. A micro gravity study to copy and reproduce mammalian cells, this ties into my argument for a T2 cell replication which in turn would be the primary cell used in identifying, attacking and rejecting Covid-19. All this ties into the fact they could retain rights to a solution for sars type infections. And thus creating intrinsic value despite some wonky TV ads and a lack luster Twitter account.
Main concern isn’t tv production, but legal rights. Patents intrinsically add value no matter the underlying product. Under the assumption of a exclusive with a pentagon funded department, any and all companies in the realm of contracting could and possibly will take up a bio-pharmacy roll. Thus exclusive rights to 3D stem cell technology in the hands of a major bio-pharma manufacturer / CO would require either royalty, buy out or shared rights giving rejuvel access to capital for RnD within the patent rights. For example I’ll link one of the patents http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6,730,498.PN.&OS=PN/6,730,498&RS=PN/6,730,498 if you go to example 8-16 they provide a use case for RT-PCR and respect to efficacy rates given the current standing use for RT-PCR testing which is use for essentially all global Covid-19 cases. This parameter of the rights that stand with respect to the Rejuvel patent could help bolster proper case counting and reduce CT reporting providing a more accurate positive / negative potential. So given they have proof to rights with respect to this type of cell testing it is that exposure that’s my core thesis of value for Rejuvel. I don’t really care about their product line. I care about the roll these patents have. If there’s interest by a large pharmaceutical company to purchase exclusive rights to testing I wouldn’t put it past them to get ownership of a patent that allows them access to NASA partnered cell studies. There’s also two more patents under the same program that’s within the Rejuvel umbrella.
Should be an announcement soon.
Thank you to all who are contacting the company, we are lighting a fire underneath their behinds to get moving. I called again today and got confirmation they are readily aware of the shareholder requests. I have emailed the Rejuvel contact team to request an update. I would expect an update soon given the volume of interest. If you’re free and have the time. Give them a call and send the contact team an email. (954) 532-5390 extension 2.
Last I checked we were .0004 nice to see a stream of avid buyers. The value is here. It’s all about to blow the top off and run like it’s tail’s on fire.
This is typical price action for these pennies, pumps and dumps. It’s all just a show. The fundamentals remain the same. I implore everyone to give Brand Labs a call and ask for David. (954) 532-5390 extension 2.
Just me calling alone won’t get anyone moving. I gave my name number and asked for the name of the person responding. It takes a couple minutes. And is important to get information from the company.
I’ll be calling back again today, will update afterwards.
This assertion of the high AS has been made for over a year. People flow in and out to say the AS is a turn off. Well they missed opportunity at .0001 .0002 so that’ll be a kicker.
That’s my job this week, I got confirmation from the CEOs son they are working on fillings, (he’s also an exec) i plan on getting in contact with the CEO by EOW.
I’ll be sure to mention it
Here’s what I’ve got, I called in a couple times, I just spoke with David’s son over at Brand Labs USA. I asked him if they could give me any information on a press release detailing current events and operations dealing with rejuvel and brand labs. His son told me they are currently working on a press release and that David was in a meeting at the moment, he took down my contact information and said he would relay my inquiry to David along with my information and have David reach out to me later today. So as of now they are currently working on updating shareholders on some key aspects of operations. He obviously could not give me much more than that, but I’m happy enough to know there are people working at brand labs, they understand shareholders requests and are working to bring the company up to standards. I’ll post again if and when David reaches out and lay out any information I can gather from they conversation.
I am in contact with operations at brand labs, in an attempt to contact Rejuvel 3D systems, any updates ill post to this board.
A year in the making with revamped website and product placement. Next comes the process to get up to date with the SEC and hopefully a shift off OTC onto a major exchange. They’ll need to prep with multiple PRs through that process once they get started on full compliance. Confirmation of a merger / acquisition, possibly retirement of shares to set up the share structure towards an uplist could be a step they plan on taking.
Beautiful
I don’t think people realize the magnitude of stem cell technology I’ll link an article explain their main attributes and functions https://www.mayoclinic.org/tests-procedures/bone-marrow-transplant/in-depth/stem-cells/art-20048117
Please read, the reason this is important is because when you’re given a situation like the one we are in currently, stem cell technology could be an explosively important function to combat new microbial invaders such as Covid-19, an infusion of naturally occurring stem cells. like the T-cells that are the first to alert, fight, and remember the makeup of a SARS like virus. This could have game changing effects. I’ll give a hypothetical, say we can study the effect certain cells that we naturally have in our body and their reaction and function in dealing with a new threat (covid 19) we can broadly copy those cells, test their function to match the exact response those cells have in the body and for people who have a deficiency in those cell counts (elderly and immuno compromised) can receive an artificial dose of those cells. Which are non invasive because they’re naturally occurring and act as if they were internally bred. This process could be even more effective than a vaccination that only looks to lessen the symptoms not the transmission. A stem cell infusion could quickly reject viral loads and cut the infection rate just out of sheer ability to respond quickly and reject these invasive cells. Along with a NASA partnership which holds legally binding contract for Rejuvel they could be the only company in the US to create this type of solution. The science seems pretty straight forward and the fact a company trading with this kind of valuation at .0004! Is absolutely astonishing. An effective result from stem cell trials would put this company ahead of Pfizer moderna and any other company that’s releasing sketchy results that were tested for success. People, if used correctly this company could be a complete game changer in the global response to any and all new viral threats for the next century, using a influx of naturally occurring cells that are bread to fight foreign invaders. Please go out, do some research on stem cell technology and it’s functions and trials. And add to this post your opinion on the viability and logic behind my thinking. I hope David sees this opportunity, this can be much more than a skin care company. This company could be a global leader in cell based technology that’s used around the world to fight deadly and highly transmissible diseases. A potential natural monopoly on an entire aspect of the pharmaceutical industry.
NUUU long waiting for a breakout in this trip name, New DD posted for product expansion. Trips stock no dilution for 12+ months ready for a big move